Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
09/2012
09/12/2012CN102659796A Fluorine-18-labeled spiropiperidine sigma-1 receptor compound and its preparation method and use
09/12/2012CN102659772A 2-aryl benzo heterocyclic compound with affinity with A beta plaques, and preparation method and application thereof
09/12/2012CN101007851B Chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
09/11/2012US8263739 also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis
09/11/2012US8263098 High alcohol content foaming compositions with silicone-based surfactants
09/11/2012US8263042 Contrast agents for myocardial perfusion imaging
09/11/2012US8263040 contrast agents for necrosis imaging, diagnosis of changes in the lymphatic system, inflammatory diseases, cardiovascular diseases, tumour imaging; radioactive materials use in radiotherapy
09/11/2012US8263039 Use of DKK-1 protein in the cancer diagnosis
09/07/2012WO2012118909A1 Radiolabelled octreotate analogues as pet tracers
09/07/2012WO2012118237A1 Anti-cancer prodrug activated by radiation or ultraviolet therapy and use thereof
09/07/2012CA2828810A1 Radiolabelled octreotate analogues as pet tracers
09/06/2012US20120225016 Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
09/06/2012US20120225015 Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression
09/06/2012US20120225014 Antibodies to cd40
09/06/2012US20120225013 Anti-mesothelin antibodies and immunoconjugates
09/06/2012US20120225012 Composition for hard tissue repair
09/06/2012US20120225011 Glassy compositions
09/05/2012EP2495563A1 Diagnostic agent for infectious diseases
09/05/2012EP2493513A1 Radiolabelled pde10 ligands
09/05/2012CN202414433U Kit used for preparing positron medicine 18F-FLT (fluorothymidine)
09/05/2012CN202410235U Purification column for purifying positron radiopharmaceuticals 18F-FDG (fluorodeoxyglucose)
09/05/2012CN101262891B Measurement of gastric acid secretion
09/05/2012CN101217983B Improved process for the production of a radioactive aerosol
09/05/2012CN101066982B Amino acid-glucose derivative 99m TC compound and its prepn process
09/05/2012CN101020697B Glucose derivative complex marked with 99mTc, 188 Re or 186Re and its preparation process
09/04/2012US8258096 Therapy procedure for drug delivery for trigeminal pain
09/04/2012US8257684 Methods for identifying and targeting autonomic brain regions
09/04/2012US8257683 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
09/04/2012US8257682 Compositions for delivery of therapeutics and other materials
09/04/2012US8257681 Compositions of high specific activity SN-117M and methods of preparing the same
09/04/2012US8257680 Catalytic radiofluorination
09/04/2012US8257433 Coated implantable medical device
08/2012
08/30/2012US20120220870 Optical imaging probes, optical imaging systems, methods of optical imaging, and methods of using optical imaging probes
08/30/2012US20120219500 Diagnostic agent for infectious diseases
08/30/2012US20120219499 Compositions and methods for detecting plectin-1 as a biomarker for cancer
08/30/2012US20120219498 Compositions and methods for inducing angiogenesis
08/30/2012US20120219497 Random ethylene oxide and non-random alkylene oxide(s) polymers
08/30/2012US20120219496 Gadolinium-linked nanoclusters
08/30/2012US20120219495 Novel tetraaza macrocyclic compound, preparation method thereof and use thereof
08/30/2012DE102010042506B4 Verfahren für eine nuklearmedizinische Untersuchung eines Patienten mithilfe einer Magnetresonanzaufnahme und einer nuklearmedizinischen Aufnahme Method for a nuclear medicine examination of a patient using a magnetic resonance imaging and nuclear medicine intake
08/29/2012EP2491953A2 Optical imaging contrast agent, use and device thereof
08/29/2012CN1886151B Pharmaceutical formulations for the sustained release of oneor more active principles and applications thereof, such as therapeutic applications
08/29/2012CN102652125A Fty720 halogenated derivatives
08/29/2012CN102652023A Labelled integrin binders
08/29/2012CN101486708B 4-nitro glyoxaline compound, preparation and use thereof
08/29/2012CN101486707B 2-methyl-5-nitro glyoxaline compound, preparation and use thereof
08/28/2012US8252909 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases
08/28/2012US8252745 Methods for treatment of headaches by administration of oxytocin
08/28/2012US8252339 Medical treatment applications of swellable and deformable microspheres
08/28/2012CA2539384C Mechanism-based targeted pancreatic beta cell imaging and therapy
08/28/2012CA2447391C Substantially homogeneous bio-affecting material having a pre-determined ratio of transferrin to doxorubicin, its method of manufacture and its method of use
08/23/2012WO2012112547A1 Core-excited nanoparticles and methods of their use in the diagnosis and treatment of disease
08/23/2012WO2012112443A2 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/23/2012WO2012112317A1 Radiobacteria for therapy of cancer
08/23/2012WO2012110835A2 Prussian blue based nanoparticle as multimodal imaging contrast material
08/23/2012WO2012081880A3 Precursor compound connected to solid support for manufacturing 18f radiopharmaceutical, method for manufacturing same, and application thereof
08/23/2012WO2012039908A4 Method and compound for treatment of cancer using phosphorous-32 labeled dna
08/23/2012WO2012021882A3 Formulation, apparatus and method for stabilizing radiopharmaceuticals
08/23/2012US20120213703 Radiolabelled pde10 ligands
08/23/2012US20120213702 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13)
08/23/2012US20120213701 Methods for tumor diagnosis and therapy
08/23/2012US20120213700 Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran
08/23/2012US20120213699 Single chain fragment of monoclonal antibody 9b9 and uses thereof
08/23/2012US20120213698 Loading technique for preparing radionuclide containing nanoparticles
08/23/2012US20120213697 Versatile nanoparticulate biomaterial for controlled delivery and/or containment of therapeutic and diagnostic material
08/23/2012CA2827076A1 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/22/2012EP2488212A2 METHOD FOR OBTAINING <sp>68<sp>GA
08/22/2012EP2488206A1 Porphyrin nanovesicles
08/22/2012EP0862464B1 Amino acid analogs for tumor imaging
08/22/2012CN102643423A 99mTc complex, preparation method, intermediate and application thereof
08/22/2012CN102643331A Micromolecular peptide probe suitable for molecular image diagnosis of lung cancer and preparation method thereof
08/22/2012CN102641511A Micromolecule lung cancer targeted radioactive therapeutic agent and preparation method thereof
08/21/2012US8246998 Injectable biodegradable particles
08/21/2012US8246930 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
08/21/2012CA2633413C Antibodies against tumor-associated antigenic target (tat) polypeptides
08/21/2012CA2449284C Alpha-fetoprotein peptides and uses thereof
08/16/2012WO2012108476A1 Method for producing radioactively labeled polypeptide
08/16/2012WO2012107579A1 Hydrophobic modified peptides and their use for liver specific targeting
08/16/2012WO2012107577A1 Hydrophobic modified peptides for liver specific diagnosis
08/16/2012US20120207679 Novel Heteroaryl Substituted Benzothiazoles
08/16/2012US20120207678 Labeled Adenosine for Use in Positron Emission Tomography
08/16/2012US20120207677 Catalytic radiofluorination
08/16/2012US20120207676 Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors
08/16/2012US20120207675 Method of Colorectal Cancer Detection by Using Radiolabeled Anti-GRP78 Peptide
08/16/2012US20120207674 Cancer-imaging agent and method of radioimaging using the same
08/16/2012US20120207673 Modified Variable Domain Molecules And Methods For Producing And Using Same
08/16/2012US20120207672 Selective detection of bone metastases in renal clear cell carcinoma
08/16/2012US20120207671 Combination treatment with vegf-c antagonists
08/16/2012US20120207670 Method for Treating Psoriasis by Administering An Anti-IL-12 Antibody
08/15/2012EP2486043A1 [18 f]- labelled analogues of flumazenil as in vivo imaging agents
08/15/2012EP2485771A1 Phosphodiesterase 1-targeting tracers and methods
08/15/2012EP1771209B1 Stabilized and lyophilized radiopharmaceutical agents
08/15/2012CN102639154A Aryloxyanilide imaging agents
08/14/2012US8241609 Method for embolization using liquid embolic materials
08/14/2012US8241606 Synthesis of a radiofluorinated peptide using photolabile protecting groups
08/09/2012WO2012106669A2 Foxc1 antibodies and methods of their use
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201754 Phosphodiesterase 1-targeting tracers and methods
08/09/2012US20120201753 Methods and compositions related to targeting wounds, regenerating tissue, and tumors
08/09/2012US20120201752 Foxc1 antibodies and methods of their use
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 243